Henoch Schönlein purpura following etanercept treatment of rheumatoid arthritis [8]

Clinical and Experimental Rheumatology

Volumn 24, Issue 2 SUPPL. 41, 2006, Pages

  Duffy, T N ^a   Genta, M ^a   Moll, S ^a   Martin, P Y ^a   Gabay, Cem ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; CYCLOPHOSPHAMIDE; ETANERCEPT; IMMUNOGLOBULIN A; METHYLPREDNISOLONE;

ADULT; ANAPHYLACTOID PURPURA; CASE REPORT; DRUG ERUPTION; FEMALE; HEMATURIA; HUMAN; IMMUNE COMPLEX DEPOSITION; IMMUNOGLOBULIN A NEPHROPATHY; LETTER; LEUKOCYTOCLASTIC VASCULITIS; PRIORITY JOURNAL; PROTEINURIA; RENOVASCULAR DISEASE; RHEUMATOID ARTHRITIS; SINUSITIS;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; IMMUNOGLOBULIN G; MIDDLE AGED; PURPURA, SCHOENLEIN-HENOCH; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA; VASCULITIS;

EID: 33745684320     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (9)

1. MILLS JA, MICHEL BA, BLOCH DA et al.: The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum 1990; 33: 1114-21.
2. MITSUHASHI H, MITSUHASHI M, TSUKADA Y, YANG S, NARUSE T: Henoch-Schönlein purpura in rheumatoid arthritis. J Rheumatol. 1994; 21: 1138-40.
3. NISHIYA K, OOSAKI F, NAKAMURA T et al.: Rheumatoid arthritis associated with Henoch-Schönlein purpura. Clin Exp Rheumatol. 2000; 18: 653-4.
4. CHO CS, MIN JK, PARK SH et al.: Protein losing enteropathy associated with Henoch-Schönlein purpura in a patient with rheumatoid arthritis. Scand J Rheumatol. 1996; 25: 334-6.
5. ROUX CH, BROCQ O, ALBERT CBV, EULLER-ZIEGLER L: Cutaneous vasculitis and glomerulonephritis in a patient taking the anti-TNF alpha agent etanercept for rheumatoid arthritis. Joint Bone Spine. 2004; 71: 444-5.
6. CUNNANE G, WARNOCK M, FYE KH, DAIKH DI: Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis. Arthritis Rheum. 2002; 47: 445-9.
7. JARRETT SJ, CUNNANE G, CONAGHAN PG et al.: Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case series. J Rheumatol. 2003; 30: 2287-91.
8. YANG YH, HUANG MT, LIN SC, LIN YT, TSAI MJ, CHIANG BL: Increased transforming growth factor-beta (TGF-beta)-secreting T cells and IgA anti-cardiolipin antibody levels during acute stage of childhood Henoch-Schönlein purpura. Clin Exp Immunol. 2000; 122: 285-90.
9. GATTORNO M, PICCO P, BARBANO G et al.: Differences in tumor necrosis factor-alpha soluble receptor serum concentrations between patients with Henoch-Schönlein purpura and pediatric systemic lupus erythematosus: pathogenetic implications. J Rheumatol. 1998; 25: 361-5.